Search Results 4821-4830 of 33795 for oral

  1. Daniel E. Wessell, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerAmerican Board of Radiology. 2011 - 2012. ChairMusculoskeletal Section, Education Exhibits Awards Committee, Radiological Society of North ...

  2. Vitiligo - Doctors and departments - Mayo Clinic

    ... Oral lichen planus, Nonmelanoma skin cancer, Tuberous sclerosis, Klippel-Trenaunay syndrome, Melasma, Alopecia areata, Diffuse capillary malformation with ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Cancer Care at Mayo Clinic · Children's Center · Head and Neck Cancer Center · Neurosurgery · Oncology (Medical) · Oral and Maxillofacial Surgery · Otolaryngology ( ...

  4. Summer Undergraduate Program in Biomedical Ethics Research

    Skilled in written and oral communication. Highly motivated to learn new research methods. Applications closed. Applications for the summer of 2026 are no ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Transoral robotic surgery, Parathyroidectomy, Reconstructive surgery, Oral surgery, Microvascular reconstruction, Trans...oral laser microsurgery, Facial ...

  6. Alirocumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Alirocumab injection is used together with a proper diet and exercise to lower LDL cholesterol in patients with hypercholesterolemia (high blood cholesterol), ...

  7. Movement Disorders Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether oral inosine dosed to moderately elevate serum urate (from ≤5.7 mg/dL to 7.1-8.0 mg/dL) over 2 years slows ...

  8. Heart Arrhythmia Clinical Trials - Mayo Clinic Research

    ... oral anticoagulants (NOACs) in patients with non-valvular atrial fibrillation. ... The primary objective of this study is to determine if left atrial appendage ...

  9. Brian J. Davis, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Oral board examiner, 2002-2025. Written Board Chair for Genitourinary Malignancies (Radiation Oncology), 2012-2017. Boston Scientific Corp: Consultant, 2017 ...

  10. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    Other oral antibiotics within 28 days of randomization (with the exception of topical antibiotics or a 1-day course with an antibiotic). However, a patient ...